ARTICLE | Company News
FDA approves Barrier's Vusion
February 17, 2006 2:54 AM UTC
FDA approved Vusion topical 0.25% miconazole from BTRX to treat Candida-associated diaper dermatitis. The company plans to launch Vusion next quarter. BTRX, which made the announcement after market cl...